Abeona Therapeutics Balance Sheet Health
Financial Health criteria checks 4/6
Abeona Therapeutics has a total shareholder equity of $45.8M and total debt of $18.7M, which brings its debt-to-equity ratio to 40.7%. Its total assets and total liabilities are $120.6M and $74.8M respectively.
Key information
40.7%
Debt to equity ratio
US$18.65m
Debt
| Interest coverage ratio | n/a |
| Cash | US$109.70m |
| Equity | US$45.77m |
| Total liabilities | US$74.82m |
| Total assets | US$120.59m |
Recent financial health updates
Is Abeona Therapeutics (NASDAQ:ABEO) Using Too Much Debt?
Sep 23
We're Not Very Worried About Abeona Therapeutics' (NASDAQ:ABEO) Cash Burn Rate
May 01We're Not Very Worried About Abeona Therapeutics' (NASDAQ:ABEO) Cash Burn Rate
Jan 04Here's Why We're Watching Abeona Therapeutics' (NASDAQ:ABEO) Cash Burn Situation
Aug 16Can Abeona Therapeutics (NASDAQ:ABEO) Afford To Invest In Growth?
Mar 31Recent updates
Is Abeona Therapeutics (NASDAQ:ABEO) Using Too Much Debt?
Sep 23We're Not Very Worried About Abeona Therapeutics' (NASDAQ:ABEO) Cash Burn Rate
May 01We're Not Very Worried About Abeona Therapeutics' (NASDAQ:ABEO) Cash Burn Rate
Jan 04Here's Why We're Watching Abeona Therapeutics' (NASDAQ:ABEO) Cash Burn Situation
Aug 16Can Abeona Therapeutics (NASDAQ:ABEO) Afford To Invest In Growth?
Mar 31Abeona: Pivotal Data Readout EB-101 Before Year End Could Boost Shareholder Value
Oct 19Abeona Therapeutics stock continues recent strong run, shares rise ~10%
Oct 04Abeona Therapeutics GAAP EPS of -$2.08, revenue of $1M
Aug 11Abeona therapeutics regains compliance with Nasdaq minimum bid price requirement
Jul 20Abeona crashes 21% as reverse stock split takes effect
Jul 05Here's Why Abeona Therapeutics (NASDAQ:ABEO) Must Use Its Cash Wisely
Mar 02Here's Why Abeona Therapeutics (NASDAQ:ABEO) Can Manage Its Debt Despite Losing Money
Aug 17Abeona Therapeutics shares rise after letter to stockholders
May 26Despite Lacking Profits Abeona Therapeutics (NASDAQ:ABEO) Seems To Be On Top Of Its Debt
Apr 28Independent Director Paul Mann Just Sold A Bunch Of Shares In Abeona Therapeutics Inc. (NASDAQ:ABEO)
Feb 21How Much Did Abeona Therapeutics'(NASDAQ:ABEO) Shareholders Earn From Share Price Movements Over The Last Three Years?
Jan 19What Kind Of Investors Own Most Of Abeona Therapeutics Inc. (NASDAQ:ABEO)?
Dec 15
Financial Position Analysis
Short Term Liabilities: ABEO's short term assets ($112.7M) exceed its short term liabilities ($18.4M).
Long Term Liabilities: ABEO's short term assets ($112.7M) exceed its long term liabilities ($56.4M).
Debt to Equity History and Analysis
Debt Level: ABEO has more cash than its total debt.
Reducing Debt: ABEO's debt to equity ratio has increased from 0% to 40.7% over the past 5 years.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: ABEO has sufficient cash runway for more than a year based on its current free cash flow.
Forecast Cash Runway: Insufficient data to determine if ABEO has enough cash runway if its free cash flow continues to grow or shrink based on historical rates.